Analystreport

Amphastar Pharmaceuticals (NASDAQ: AMPH) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong sell" rating.

Amphastar Pharmaceuticals, Inc.  (AMPH) 
Last amphastar pharmaceuticals, inc. earnings: 3/12 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.amphastar.com/investor-relations